Leishmania major proteophosphoglycan is expressed by amastigotes and has an immunomodulatory effect on macrophage function

Microbes and Infection

Volumn 1, Issue 8, 1999, Pages 589-599

  Piani, Aline ^b   Ilg, Thomas ^a   Elefanty, Andrew G ^b   Curtis, Joan ^b   Handman, Emanuela ^b  

^a MAX PLANCK INST FÜR BIOLOGIE   (Germany)

^b NONE

Author keywords

Immunomodulation; Lipophosphoglycan; Nitric oxide; Proteophosphoglycan; TNF alpha

Indexed keywords

GAMMA INTERFERON; GLYCAN DERIVATIVE; GLYCOPROTEIN; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

AMASTIGOTE; ANIMAL CELL; ARTICLE; CELL FUNCTION; IMMUNOMODULATION; LEISHMANIA MAJOR; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANIMALIA; LEISHMANIA MAJOR; PROTOZOA;

EID: 0032742402     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)80058-6     Document Type: Article

References (50)

1. Alexander J., Russell D.G. The interaction of Leishmania species with macrophages. Adv. Parasitol. 31:1992;175-254.
2. Adler S., Ber M. The transmission of Leishmania tropica by the bite of Phlebotomus papasi. Indian J. Med. Res. 29:1941;803-809.
3. Adler S., Theodor O. The behaviour of cultures of Leishmaina sp. in Phlebotomus papasi. Ann. Trop. M. 21:1927;111-135.
4. Chang K.P., Dwyer D.M. Leishmania donovani-hamster macrophage interactions in vitro: cell entry, intracellular survival and multiplication of amastigotes. J. Exp. M. 147:1978;515-530.
5. Handman E., Goding J.W. The Leishmania receptor for macrophages is a lipid containing glycoconjugate. EMBO J. 4:1985;329-336.
6. Russell D.G., Talamas-Rohana P. Leishmania and the macrophage: a marriage of inconvenience. Immunol. Today. 10:1989;328-333.
7. Brittingham A., Mosser D.M. Exploitation of the complement system by Leishmania promastigotes. Parasitol. Today. 12:1996;444-447.
8. McConville M.J., Ferguson M.A.J. The structure, biosynthesis and function of glycosylated-phosphatidylinositols in the parasitic protozoa and higher eukaryotes. Biochem. J. 294:1993;305-324.
9. Ilg T., Stierhof Y.D., Wiese M., McConville M.J., Overath P. Characterization of phosphoglycan-containing secretory products of Leishmania. Parasitology. 108:1994;S63-S71.
10. Turco S.J., Descoteaux A. The lipophosphoglycan of Leishmania parasites. Annu. Rev. Microbiol. 46:1992;65-94.
11. Carrera L., Gazzinelli R.T., Badolato R. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. M. 183:1996;26-515.
12. Frankenburg S., Leibovici V., Mansbach N., Turco S.J., Rosen G. Effect of glycolipids of Leishmania parasites on human monocyte activity. Inhibition by lipophosphoglycan. J. Immunol. 145:1990;4284-4289.
13. Hatzigeorgiou D.E., Geng J., Zhu B. Lipophosphoglycan from Leishmania suppresses agonist-induced interleukin 1β gene expression in human monocytes via a unique promoter sequence. Proc. Natl. Acad. Sci. USA. 93:1996;14708-14713.
14. Proudfoot L., Nikolaev A.V., Feng G.J. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc. Natl. Acad. Sci. USA. 93:1996;10984-10989.
15. Green S.J., Meltzer M.S., Hibbs J.B.J., Nacy C.A. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144:1990;278-283.
16. Liew F.Y., Millott S., Parkinson C., Palmer R.M., Moncada S. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:1990;4794-4797.
17. Ilg T., Stierhof Y.D., Craik D. Purification and structural characterization of a filamentous, mucin-like proteophosphoglycan secreted by Leishmania parasites. J. Biol. Chem. 271:1996;21583-21596.
18. Ilg T., Etges R., Overath P. Structure of Leishmania mexicana lipophosphoglycan. J. Biol. Chem. 267:1992;6834-6840.
19. Stierhof Y.D., Ilg T., Russell D.G., Hohenberg H., Overath P. Characterization of polymer release from the flagellar pocket of Leishmania mexicana promastigotes. J. Cell Biol. 125:1994;321-331.
20. Ilg T., Stierhof Y.D., McConville M.J., Overath P. Purification, partial characterization and immunolocalization of a proteophosphoglycan secreted by Leishmania mexicana amastigotes. Eur. J. Cell. Biol. 66:1995;205-215.
21. Kelleher M., Bacic A., Handman E. Identification of a macrophage-binding determinant on lipophosphoglycan from Leishmania major promastigotes. Proc. Natl. Acad. Sci. USA. 89:1992;6-10.
22. Handman E., Hocking R.E., Mitchell G.F., Spithill T.W. Isolation and characterization of infective and non-infective clones of Leishmania tropica. Mol. Biochem. Parasitol. 7:1983;111-126.
23. Glaser T.A., Wells S.J., Spithill T.W. Leishmania major and L. donovani: a method for rapid purification of amastigotes. Exp. Parasitol. 71:1990;343-345.
24. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
25. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
26. Johnson D.A., Gautch J.W., Sportsman J.R., Elder J.H. Improved technique utilizing non fat dry milk for analysis of protein and nucleic acids transferred to nitrocellulose. Gene Anal. Tech. 1:1984;3-8.
27. Ilg T., Menz B., Winter G. Monoclonal antibodies to Leishmania mexicana promastigote antigens. I. Secreted acid phosphatase and other proteins share epitopes with lipophosphoglycan. J. Cell Sci. 99:1991;175-180.
28. Ilg T., Harbecke D., Wiese M., Overath P. Monoclonal antibodies directed against Leishmania secreted acid phosphatase and lipophosphoglycan. Partial characterization of private and public epitopes. Eur. J. Biochem. 217:1993;603-615.
29. Chang K.P. Human cutaneous Leishmania in a mouse macrophage line: propagation and isolation of intracellular parasites. Science. 209:1980;1240-1242.
30. Moody S.F., Handman E., McConville M.J., Bacic A. The structure of Leishmania major amastigote lipophosphoglycan. J. Biol. Chem. 268:1993;18457-18466.
31. Kolb J.P., Paul-Eugene N., Damais C. Interleukin-4 stimulates cGMP production by IFN-γ-activated human monocytes. J. Biol. Chem. 269:1994;9811-9816.
32. McConville M.J., Blackwell J.M. Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids. J. Biol. Chem. 266:1991;15170-15179.
33. Moody S.F., Handman E., Bacic A. Structure and antigenicity of the lipophosphoglycan from Leishmania major amastigotes. Glycobiology. 1:1991;419-424.
34. Alexander J., Vickerman K. Fusion of host cell secondary lysosomes with the parasitophorous vacuoles of Leishmania mexicana-infected macrophages. J. Protozool. 22:1975;502-508.
35. Antoine J.C., Jouanne C., Ryter A., Zilberfarb V. Leishmania mexicana: a cytochemical and quantitative study of lysosomal enzymes in infected rat bone marrow-derived macrophages. Exp. Parasitol. 64:1987;485-498.
36. Antoine J.C., Prina E., Jouanne C., Bongrand P. Parasitophorous vacuoles of Leishmania amazonensis-infected macrophages maintain an acidic pH. Infect. Immun. 58:1990;779-787.
37. Prina E., Antoine J.C., Wiederanders B., Kirschke H. Localization and activity of various lysosomal proteases in Leishmania amazonensis-infected macrophages. Infect. Immun. 58:1990;1730-1737.
38. Russell D.G., Xu S., Chakraborty P. Intracellular trafficking and the parasitophorous vacuole of Leishmania mexicana-infected macrophages. J. Cell Sci. 103:1992;1193-1210.
39. Lang T., Hellio R., Kaye P.M., Antoine J.C. Leishmania donovani-infected macrophages: characterization of the parasitophorous vacuole and potential role of this organelle in antigen presentation. J. Cell Sci. 107:1994;2137-2150.
40. + T cells during initiation of infection. J. Exp. M. 179:1994;447-456.
41. Zhan Y., Cheers C. Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors. J. Immunol. 161:1998;1447-1453.
42. Chang K.P. Cellular and molecular mechanisms of intracellular symbiosis in leishmaniasis. Int. Rev. Cytol. 14:1983;267-305.
43. Chang K.P. Leishmania donovani-macrophage binding mediated by surface glycoproteins/antigens: characterization in vitro by a radioisotopic assay. Mol. Biochem. Parasitol. 4:1981;67-76.
44. Kelleher M., Curtis J.M., Sacks D.L., Handman E., Bacic A. Epitope mapping of monoclonal antibodies directed against lipophosphoglycan of Leishmania major promastigotes. Mol. Biochem. Parasitol. 66:1994;187-200.
45. Talamas P., Russell D.G. Leishmania lipophosphoglycan (LPG) binds to the CR3, LFA-1, p150, 95 family of adhesion receptors. J. Cell Biochem. Suppl. 13E:1989;158.
46. Peters C., Stierhof Y.D., Ilg T. Proteophosphoglycan secreted by Leishmania mexicana amastigotes causes vacuole formation in macrophages. Infect. Immun. 65:1997;783-786.
47. Probst P., Skeiky Y.A., Steeves M. A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-α production and expression of B7-1 in human monocyte-derived antigen-presenting cells. Eur. J. Immunol. 27:1997;2634-2642.
48. de Diego J., Punzon C., Duarte M., Fresno M. Alteration of macrophage function by a Trypanosoma cruzi membrane mucin. J. Immunol. 159:1997;4983-4989.
49. Fresno M., Hernandez-Munain C., de Diego J. Trypanosoma cruzi: identification of a membrane cystein proteinase linked through a GPI anchor. Brazilian J. Med. Biol. Res. 27:1994;431-437.
50. Liew F.Y., O'Donnell C.A. Immunology of leishmaniasis. Adv. Parasitol. 32:1993;161-259.